Report
Boltz says it raised $110M for AI-powered biomolecular design
Boltz says Bessemer led the round, following 50-fold growth in molecular token usage since June.
TLDR
The ambition, according to Boltz, is AI-powered biomolecular design for every scientist. The company says it raised a $110 million Series A led by Bessemer, following 50-fold growth in molecular token usage since June. It also reports partnerships with six of the world’s 20 largest pharmaceutical companies.
Combined views
12.2K
3 Sources, first seen ago
Comments